Maternal serum screening in Newfoundland and Labrador: Do attitude and knowledge affect physicians' practice?

Canadian Family Physician

Volumn 52, Issue 10, 2006, Pages

  Cavanagh, Jonathan ^a,b   Mathews, Maria ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; MATERNAL SERUM; MEDICAL PRACTICE; NEURAL TUBE DEFECT; PREGNANT WOMAN; PRENATAL CARE; PRENATAL DIAGNOSIS; REVIEW; RISK FACTOR; SCREENING TEST; TRISOMY;

ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; CANADA; CHROMOSOMES, HUMAN, PAIR 18; CLINICAL COMPETENCE; CROSS-SECTIONAL STUDIES; DOWN SYNDROME; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEURAL TUBE DEFECTS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PREGNANCY; PRENATAL DIAGNOSIS; QUESTIONNAIRES; TRISOMY;

EID: 33845689870     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Wald NJ, Cuckle HS, Densem JW, Nanchahal K, Royston P, Chard T, et al. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 1988;297:883-7.
2. Canadian Task Force on the Periodic Health Examination. Periodic Health Examination (CTFPHE), 1994 update. 3. Primary and secondary prevention of neural tube defects. CMAJ 1994;151:159-66.
3. Society of Obstetricians and Gynaecologists of Canada. Committee opinion number 79. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers screening. J SOGC 1999;21:887-91.
4. Crane J, Sun C, Hutchens D, Crowley M. The epidemiology of neural tubes defects in Newfoundland and Labrador. J SOGC 2001;23:510-4.
5. Chandra S, Crane J, Hutchinson D, Bennett K, O'Grady T, Duff A. Maternal serum screening: practice patterns of physicians in Newfoundland. J SOGC 2003;25:825-9.
6. Carroll JC, Reid AJ, Woodward CA, Permaul-Woods JA, Domb S, Ryan G, et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. CMAJ 1997;156:775-84.
7. Permaul-Woods JA, Carroll JC, Reid AJ, Woodward CA, Ryan G, Domb S, et al. Going the distance: the influence of practice location on the Ontario Maternal Serum Screening Program. CMAJ 1999;161:381-5.
8. Chodriker BN, Evans JA. Maternal serum AFP screening programs: the Manitoba experience. In: Royal Commission on New Reproductive Technologies. Current practice of prenatal diagnosis in Canada. Vol 13. Research studies. Ottawa, Ont: Royal Commission on New Reproductive Technologies; 1993. p. 535-610.
9. Newfoundland and Labrador Medical Genetics Program. Newfoundland and Labrador MSS 2003 Program Statistics. St John's, Nfld: Newfoundland and Labrador Medical Genetics Program; 2003.
10. Summers AM, Farrell SA, Huang T, Meier C, Wyatt PR. Maternal serum screening in Ontario using the triple marker test. J Med Screen 2003;10(3):107-11.
11. Carroll JC, Brown JB, Reid AJ, Pugh P. Women's experience of maternal serum screening. Can Fam Physician 2000;46:614-20.
12. Van den Berg M, Timmermans DR, Kleinveld JH, Garcia E, van Vugt JM, van der Wal G. Accepting or declining the offer of prenatal screening for congenital defects: uptake and women's reasons. Prenat Diagn 2005;25:84-90.